Abstract
Get full access to this article
View all access options for this article.
References
1.Official Journal of the European Union . Available at: http://www.europa.eu.int/eur-lex/en/archive/2004/l_13620040430en.html.
2.The Rules governing medicinal products in the European Union . Available at: http://pharmacos.eudra.org/F2/eudralex/index.htm.
3.Addressing the needs of small and medium-sized enterprises (SMEs) . Available at: http://www.emea.eu.int/SME/SMEoverview.htm.
4.Pharmaceutical Journal (press report) of Wyeths decision to abandon the OTC launch of Zoton . Available at: http://www.pjonline.com/editorial/20050423/news/p481zoton.html.
5.UK Government Department of Health Self Care Initiative. Available at: http://www.dh.gov.uk/PolicyAndGuidance/OrganisationPolicy/SelfCare/fs/en.
6.AESGP The Economic and Public Health Value of Self-medication . Available at: http://www.aesgp.be/ephv/2004study.pdf.
7.
Roth-Behrendt
D.
, Vice-President of the European Parliament . Available at: http://www.aesgp.be/LondonNov2005/ReportLondonNovember2005.pdf.
8.UK Government Better Regulation Executive . Available at: http://www.betterregulation.gov.uk.
9.
Report of MHRA approach to tackling ‘red tape’ presented by the Right Honorable Jane Kennedy MP at November 2005 AESGP meeting. Available at: http://www.aesgp.be/LondonNov2005/(1)_KENNEDY.pdf.